Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Author:

Hammel Pascal1,Huguet Florence2,van Laethem Jean-Luc3,Goldstein David4,Glimelius Bengt5,Artru Pascal6,Borbath Ivan7,Bouché Olivier8,Shannon Jenny9,André Thierry10,Mineur Laurent11,Chibaudel Benoist12,Bonnetain Franck13,Louvet Christophe14

Affiliation:

1. Department of Digestive Oncology, Beaujon Hospital (AP-HP), Clichy, France

2. Department of Radiotherapy, Tenon Hospital (AP-HP), Paris, France

3. Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium

4. Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia5Australasian Gastrointestinal Trials Group (AGITG), Camperdown, Australia6Prince of Wales Clinical School, University of New South Wales, Sydney, Australia

5. Department of Radiology, Oncology, and Radiation Science, University of Uppsala, Uppsala, Sweden

6. Department of Gastroenterology, Jean Mermoz Hospital, Lyon, France

7. Department of Gastroenterology, Saint-Luc University Clinics, Brussels, Belgium

8. Department of Gastroenterology, Robert Debré Hospital, Reims, France

9. Australasian Gastrointestinal Trials Group (AGITG), Camperdown, Australia6Prince of Wales Clinical School, University of New South Wales, Sydney, Australia11Department of Medical Oncology, Nepean Hospital NSW, Sydney, Australia

10. Department of Medical Oncology, Saint-Antoine Hospital (AP-HP), Paris, France

11. Department of Radiotherapy and Medical Oncology, Sainte-Catherine Institute, Avignon, France

12. Department of Medical Oncology, Franco-British Hospital Institute, Levallois-Perret, France15Oncology Multidisciplinary Research Group (GERCOR), Paris, France

13. Department of Methodology and Quality of Life in Oncology, Hospital Minjoz, Besançon, France

14. Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3